Advertisement
AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


AJPH First Look, published online ahead of print Aug 30, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
AJPH.2004.056150v1
95/10/1737    most recent
Right arrow Submit a response
Right arrow purchase articles
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Get other permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Farley, J.
Right arrow Articles by Farley, T. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Farley, J.
Right arrow Articles by Farley, T. A.
©
American Journal of Public Health, 10.2105/AJPH.2004.056150


Research and Practice

Feasibility and Outcome of HCV Treatment in a Canadian Federal Prison Population

John Farley 1, Shawn Vasdev 2, Benedikt Fischer 3*, Emma Haydon 3, Jürgen Rehm 3, Theresa A. Farley 4

1 University of British Columbia and John Farley, Inc.
2 University of Ottawa
3 Centre for Addiction and Mental Health and University of Toronto
4 John Farley, Inc.

* To whom correspondence should be addressed. E-mail: benedikt_fischer{at}camh.net.


   Abstract

We assessed feasibility and outcome of hepatitis C virus (HCV) treatment in male correctional inmates in British Columbia, Canada. We reviewed the medical charts of 114 treated inmates; 80 had complete data for treatment outcome. Approximately 4 of 5 inmates completed treatment (78.8%); 66.3% achieved sustained virological response. Those who completed treatment, those with injection drug use as a risk factor, and those with genotypes 2 and 3 were significantly more likely to achieve sustained virological response. HCV treatment in correctional inmates is feasible and effective.

Key Words: Health Care Facilities/Services, Access to Care, Hepatitis, Public Health Practice




This article has been cited by other articles:


Home page
AJPHHome page
C. K. Martin, J. E. Hostetter, and J. J. Hagan
New Opportunities for the Management and Therapy of Hepatitis C in Correctional Settings
Am J Public Health, January 1, 2010; 100(1): 13 - 17.
[Abstract] [Full Text] [PDF]


Home page
J Am Acad Psychiatry LawHome page
R. L. Trestman, J. Ford, W. Zhang, and V. Wiesbrock
Current and Lifetime Psychiatric Illness Among Inmates Not Identified as Acutely Mentally Ill at Intake in Connecticut's Jails
J Am Acad Psychiatry Law, December 1, 2007; 35(4): 490 - 500.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2005 by the American Public Health Association